Close Menu

NEW YORK (GenomeWeb News) – Dionex, a maker of liquid chromatography analysis systems, said today that it plans to buy ESA Biosciences' life sciences assets from ESA's parent company, Magellan Biosciences, including ESA's HPLC systems and clinical assays, as well as lab services.

The asset purchase agreement will give Sunnyvale, Calif.-based Dionex three lines of HPLC detectors. These products include the Corona Universal Charged Aerosol Detectors, which Dionex will sell with its own HPLC equipment or directly on third party systems.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.